Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Altimmune (ALT) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Altimmune's Return on Capital Employed [ROCE] was -23.92% in Q2 2026, up 33.41 percentage points from -57.34% a year earlier and up 8.77 percentage points from the prior quarter.

Analysis

Altimmune (ALT) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Altimmune came in at -48.55%, up 14.17 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -8.72 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -62.72% in FY2024 (-13.93 pp), -48.78% in FY2023 (-3.98 pp), -44.80% in FY2022 (+0.55 pp) and -45.35% in FY2021 (-5.51 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q4 2016.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for five straight quarters, with an average year-over-year change of +10.31 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2026 (a gain of 38.21 percentage points); the worst was Q1 2022 (a drop of 27.12 percentage points).
  • Per Business Quant data, ALT's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -32.69% (Q1 2026), -40.35% (Q4 2025) and -47.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Altimmune 530.91 Mn 530.91 Mn - -23.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.92%
Mar 31, 2026 -32.69%
Dec 31, 2025 -40.35%
Sep 30, 2025 -47.17%
Jun 30, 2025 -57.34%
Mar 31, 2025 -70.90%
Dec 31, 2024 -77.50%
Sep 30, 2024 -73.65%
Jun 30, 2024 -66.21%
Mar 31, 2024 -53.66%
Dec 31, 2023 -54.36%
Sep 30, 2023 -52.37%
Jun 30, 2023 -50.42%
Mar 31, 2023 -49.44%
Dec 31, 2022 -44.08%
Sep 30, 2022 -43.91%
Jun 30, 2022 -50.06%
Mar 31, 2022 -52.58%
Dec 31, 2021 -46.24%
Sep 30, 2021 -36.71%
API Access

Altimmune Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALT&period=max&api_key=YOUR_API_KEY